Search research articles
Contact Us
Filters
Showing results (211-220 of 267) with videos related to
Page
of 27
Sort By:
The Prostate
|
October 5, 2023
Targeting the fibroblast growth factor pathway in molecular subtypes of castration-resistant prostate cancer
Mark P Labrecque, Lisha G Brown, Ilsa M Coleman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 12, 2026
Prognostic Value of Cycle 1 SPECT SUV<sub>mean</sub> in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with <sup>177</sup>Lu-PSMA-617
Alireza Ghodsi, Ridvan A Demirci, Roman Gulati, et al.
JCO Precision Oncology
|
July 17, 2020
<i>CDK12</i>-Mutated Prostate Cancer: Clinical Outcomes With Standard Therapies and Immune Checkpoint Blockade
Michael T Schweizer, Gavin Ha, Roman Gulati, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 10, 2017
MSH2 Loss in Primary Prostate Cancer
Liana B Guedes, Emmanuel S Antonarakis, Michael T Schweizer, et al.
Urologic Oncology
|
August 26, 2022
Changes in skeletal muscle and adipose tissue during cytotoxic chemotherapy for testicular germ cell carcinoma and associations with adverse events
Anthea Phuong, J Peter Marquardt, Ryan O'Malley, et al.
The Oncologist
|
March 5, 2026
Molecular Landscape of Prostate Cancers with Clival Metastases
Pornlada Likasitwatanakul, Steven M Blinka, Jabra G Zarka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 21, 2024
A Signal-Finding Study of Abemaciclib in Heavily Pretreated Patients with Metastatic Castration-Resistant Prostate Cancer: Results from CYCLONE 1
Neeraj Agarwal, Daniel Castellano, Teresa Alonso-Gordoa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 17, 2020
Regulation of CEACAM5 and Therapeutic Efficacy of an Anti-CEACAM5-SN38 Antibody-drug Conjugate in Neuroendocrine Prostate Cancer
Diana C DeLucia, Thomas M Cardillo, Lisa Ang, et al.
Urology
|
June 21, 2024
A Multicenter Evaluation of Treatment-associated Changes in Body Composition in Men With Germ Cell Tumors of the Testis: Implications for Adverse Events and Complications
Claire Buxton, Benjamin N Schmeusser, Sarah K Holt, et al.
JCO Precision Oncology
|
April 25, 2024
Genomic Correlates of Prostate-Specific Membrane Antigen Expression and Response to <sup>177</sup>Lu-PSMA-617: A Retrospective Multicenter Cohort Study
Ruben Raychaudhuri, George Mo, Abuzar Moradi Tuchayi, et al.
Page
of 27
Search research articles
Search
Showing results (211-220 of 267) with videos related to
Sort By:
Page
of 27
The Prostate
|
October 5, 2023
Targeting the fibroblast growth factor pathway in molecular subtypes of castration-resistant prostate cancer
Mark P Labrecque, Lisha G Brown, Ilsa M Coleman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 12, 2026
Prognostic Value of Cycle 1 SPECT SUV<sub>mean</sub> in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with <sup>177</sup>Lu-PSMA-617
Alireza Ghodsi, Ridvan A Demirci, Roman Gulati, et al.
JCO Precision Oncology
|
July 17, 2020
<i>CDK12</i>-Mutated Prostate Cancer: Clinical Outcomes With Standard Therapies and Immune Checkpoint Blockade
Michael T Schweizer, Gavin Ha, Roman Gulati, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 10, 2017
MSH2 Loss in Primary Prostate Cancer
Liana B Guedes, Emmanuel S Antonarakis, Michael T Schweizer, et al.
Urologic Oncology
|
August 26, 2022
Changes in skeletal muscle and adipose tissue during cytotoxic chemotherapy for testicular germ cell carcinoma and associations with adverse events
Anthea Phuong, J Peter Marquardt, Ryan O'Malley, et al.
The Oncologist
|
March 5, 2026
Molecular Landscape of Prostate Cancers with Clival Metastases
Pornlada Likasitwatanakul, Steven M Blinka, Jabra G Zarka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 21, 2024
A Signal-Finding Study of Abemaciclib in Heavily Pretreated Patients with Metastatic Castration-Resistant Prostate Cancer: Results from CYCLONE 1
Neeraj Agarwal, Daniel Castellano, Teresa Alonso-Gordoa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 17, 2020
Regulation of CEACAM5 and Therapeutic Efficacy of an Anti-CEACAM5-SN38 Antibody-drug Conjugate in Neuroendocrine Prostate Cancer
Diana C DeLucia, Thomas M Cardillo, Lisa Ang, et al.
Urology
|
June 21, 2024
A Multicenter Evaluation of Treatment-associated Changes in Body Composition in Men With Germ Cell Tumors of the Testis: Implications for Adverse Events and Complications
Claire Buxton, Benjamin N Schmeusser, Sarah K Holt, et al.
JCO Precision Oncology
|
April 25, 2024
Genomic Correlates of Prostate-Specific Membrane Antigen Expression and Response to <sup>177</sup>Lu-PSMA-617: A Retrospective Multicenter Cohort Study
Ruben Raychaudhuri, George Mo, Abuzar Moradi Tuchayi, et al.
Page
of 27